Does Mounjaro Make You Cold and Tired?

Feeling cold on tirzepatide is largely a calorie-reduction effect: less food means less metabolic heat generation.
Fatigue is one of the more commonly reported side effects and tends to be most noticeable in the first few weeks or after a dose increase.
Both sensations usually ease as your body adjusts to the new intake level, though this varies from person to person.
Persistent or worsening cold intolerance alongside significant fatigue should be discussed with your prescriber, as thyroid function and other factors may be relevant.

Feeling cold and tired on Mounjaro is a recognised pattern, and there is a biological reason for it. As your body takes in fewer calories, it produces less heat and has less fuel for day-to-day energy — both are documented effects seen in clinical trials, not signs that something has gone wrong. These are prescription-only medicines, and a clinician assesses your suitability before treatment begins. If symptoms are severe or persistent, your prescriber needs to know. The NHS tirzepatide page lists fatigue and related symptoms among the reported effects worth monitoring.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Why tirzepatide affects your temperature and energy — and what the evidence says

What the clinical data tells us about cold intolerance and fatigue

In the SURMOUNT-1 trial, published in the New England Journal of Medicine, participants on the highest tirzepatide doses lost around 20–21% of their body weight over 72 weeks. That scale of weight reduction is significant metabolically. Adipose tissue generates heat; as fat mass falls, the body simply produces less of it. Muscle also plays a role in thermogenesis, and because aggressive calorie restriction can reduce lean mass alongside fat, participants sometimes notice a reduced tolerance to cold environments, particularly in their hands and feet.

Fatigue follows a similar logic. When calorie intake drops sharply, the body's short-term energy availability falls with it. Tirzepatide reduces appetite markedly, which is the mechanism behind its effectiveness, but that appetite suppression can mean some people are eating significantly less than they realise. The result can feel like a general flatness: less drive, earlier tiredness, more need for rest. This is explored further on our page about fatigue and Mounjaro.

Fatigue is listed among the reported side effects of tirzepatide and tends to cluster around the start of treatment and the days following a dose increase, when the appetite-suppressing effect is at its sharpest. Most people notice it easing within a couple of weeks at any given dose.

The calorie link, and what you can do about it

One practical habit worth building: before you assume the cold or the tiredness is the medicine itself, check what you have actually eaten that day. Many people on tirzepatide find they have consumed very little without noticing, because the urge to eat simply was not there. A quick mental tally (or a glance at any food diary you keep) takes under a minute and can reveal whether you are consistently under-fuelling.

Protein is particularly important here. It is more thermogenic than carbohydrate or fat, meaning the body generates more heat digesting it, and it preserves lean muscle mass that contributes to ongoing calorie burn. Getting adequate protein across meals, even small ones, tends to reduce both the cold feeling and the energy dip. Hydration matters too; dehydration amplifies fatigue and is easy to underestimate when appetite is low and thirst cues are dampened.

If cost or treatment planning is on your mind alongside these symptoms, our Mounjaro cost context page covers what UK private treatment typically includes. The short version is that clinical support for exactly these kinds of questions is built in.

When to treat cold or tiredness as a signal to act

Most cold intolerance and fatigue on Mounjaro is benign and transient. Some situations deserve more attention. If you feel severely or persistently cold in a way that seems disproportionate to the weather or your weight loss so far, it is worth raising with your prescriber, underactive thyroid, anaemia and other conditions can produce the same symptoms and may need ruling out. These are not caused by tirzepatide, but they can be unmasked when someone is eating less and their system is under increased metabolic pressure.

Fatigue that does not improve between dose increases, or that is accompanied by symptoms such as dizziness, palpitations, or feeling faint when standing, also warrants a conversation. Our full Mounjaro side effects overview covers the broader symptom picture, including the signs that need urgent attention.

For context on the mechanism behind tirzepatide's effects, the explanation of why tirzepatide affects energy levels goes into more detail on the dual GIP and GLP-1 pathway. And if you are finding other unexpected symptoms alongside the fatigue (burping is a common one) the gastric-emptying piece on burping explains the shared root cause.

Getting the right support during treatment

Tirzepatide is a prescription-only medicine for weight management in the UK, assessed and prescribed by a GPhC-registered clinician. What that means in practice is that you should never be navigating symptoms alone. If something feels off, the right move is to contact your prescriber, not to wait it out and hope for the best.

At nume, our prescribers are reachable seven days a week for aftercare. Cold intolerance and tiredness are among the most common questions they hear, particularly in the first month of treatment and after moving to a higher dose. If you are weighing up whether to start, our treatment consultation page is the place to ask those questions directly. A real clinician reads your consultation the same day; there is no automated triage standing between you and a qualified answer.

You can also read about how we approach clinical oversight on our about us page, or explore the wider evidence for weight-loss treatment options through our weight-loss treatments overview.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions